Q301--Tissue Typing and Immunogenetics Lab Services Intent to Sole Source

Where this opportunity stands

Every notice posted under solicitation 36C24225Q1071 in this department, oldest first.

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

• Answer the notice: this is when the requirement can still be shaped.
• Contact the contracting officer named on the notice.
• Check who won similar work; they are the likely bidders.

What the notice says

Who won similar work

7 award notices on SAM.gov in the last 24 months. Matched by: Same office (242-NETWORK CONTRACT OFFICE 02 (36C242)), same product/service code (PSC) Q301 and NAICS 621511.

Single-winner award sizes (7): middle half $665K to $2.2M, median $1.3M; range $600K to $6.8M.

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

• Oct 1, 2026LABORATORY CORPORATION$1.3MQ301--CYTOPATHOLOGY AND NEXT GENERATION SEQUENCING TESTING SERVICESNo listed company matched (Materiality N/A)
• Jun 30, 2026LABORATORY CORPORATION$2.4MEMERGENCY BRIDGE- Downstate Reference LabNo listed company matched (Materiality N/A)
• Jun 24, 2026QUEST DIAGNOSTICS INCORPORATED$675KQ301--V797D-70090 | 36C24226A0046 | URGENT Bridge Specialized Genetic and Esoteric Lab Testing FSS-BPA LSJ AttachedMateriality: <0.01% of $DGX revenue (Low) SEC
• Jun 1, 2026THE ROGOSIN INSTITUTE INC$2.0MQ301--Tissue Typing and Immunogenetics Lab ServicesNo listed company matched (Materiality N/A)
• Apr 1, 2026Eurofins Transplant Genomics, LLC$600KQ301--DONOR-DERIVED CELL FREE DNA TESTINGNo listed company matched (Materiality N/A)
• Dec 4, 2025QUEST DIAGNOSTICS INCORPORATED$6.8MQ301--Base-Reference Laboratory Testing for VISN2 North (VA-26-00003512)Materiality: 0.07% of $DGX revenue (Low) SEC
• Jun 23, 2025QUEST DIAGNOSTICS INCORPORATED$655KQ301--6-Month Bridge VISN 2 South Specialized Genetic and Esoteric Lab Testing FSS-BPA LSJ AttachedMateriality: <0.01% of $DGX revenue (Low) SEC

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.